Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Heron Therapeutics Inc.

    NASDAQ: HRTX · Real-Time Price · USD
    1.33
    -0.02 (-1.48%)
    At close: Aug 15, 2025, 3:47 PM

    Heron Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 144.28M 127.04M 107.67M 86.35M
    Cost of Revenue
    		 38.65M 65.11M 54.87M 46.02M
    Gross Profit
    		 105.64M 61.94M 52.8M 40.33M
    Operating Income
    		 -11.53M -110.61M -174.66M -217.83M
    Interest Income
    		 3.55M 3.36M 1.64M 433K
    Pretax Income
    		 -13.58M -110.56M -182.02M -220.68M
    Net Income
    		 -13.58M -110.56M -182.02M -220.68M
    Selling & General & Admin
    		 100.48M 119.82M 144.75M 127.33M
    Research & Development
    		 16.68M 39.13M 82.7M 130.82M
    Other Expenses
    		 n/a 13.6M n/a n/a
    Operating Expenses
    		 117.17M 172.55M 227.46M 258.15M
    Interest Expense
    		 6.03M 3.87M 2.47M 2.41M
    Selling & Marketing Expenses
    		 47.09M 61.34M 82.51M 87.18M
    Cost & Expenses
    		 155.81M 237.66M 282.33M 304.17M
    Income Tax Expense
    		 n/a n/a -47.51M -3.02M
    Shares Outstanding (Basic)
    		 152.45M 138.13M 108.88M 98.47M
    Shares Outstanding (Diluted)
    		 152.45M 138.13M 108.88M 98.47M
    EPS (Basic)
    		 -0.09 -0.8 -1.67 -2.24
    EPS (Diluted)
    		 -0.09 -0.8 -1.67 -2.24
    EBITDA
    		 -5.06M -103.79M -176.66M -215.25M
    EBIT
    		 -7.55M -106.69M -179.55M -218.27M
    Depreciation & Amortization
    		 2.49M 2.9M 2.89M 3.02M

    Add to Watchlist